BIOX Stock 12 Month Analyst Forecast
Eps Overview
Consensus Rating
Consensus Price Target
Highest Price Target
$6.00
919.37% Upside
Mean Price Target
$3.60
511.62% Upside
Lowest Price Target
$2.25
282.26% Upside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Actual EPS vs Estimated EPS
BIOX Earnings Per Share (EPS) History
According to financial reports, BIOX (NYSE: BIOX) reported an actual EPS of $-0.1183 for the quarter ending on Nov 12, 2025, compared to an estimated $0.07, resulting in a -269.00% surprise. In the prior quarter (Sep 09, 2025), BIOX recorded an actual EPS of $-0.7 with a -800.00% surprise. See BIOX's full earnings history.
Earnings History
EPS Surprise Factor Analysis
BIOX has experienced notable EPS surprises, with the latest quarter ending Nov 12, 2025 showing a -269.00% miss. Previously, the quarter ending Sep 09, 2025 recorded a -800.00% miss. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
| Report Date | Actual | Forecast | Surprise Factor |
|---|---|---|---|
| Nov 12, 2025 | -0.1183 | 0.07 | -269.00% |
| Sep 09, 2025 | -0.7 | 0.1 | -800.00% |
| May 21, 2025 | -0.02 | -0.1 | -80.00% |
| Feb 11, 2025 | 0.01 | 0.14 | -92.86% |
| Nov 11, 2024 | -0.09 | -0.01 | +800.00% |
| Sep 09, 2024 | -0.03 | 0.2 | -115.00% |

